Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vascular endothelial growth factor receptors: expression and function in solid tumors.

Jane S Wey1, Oliver Stoeltzing, Lee M Ellis

  • 1Department of Surgical Oncology, Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

Clinical Advances in Hematology & Oncology : H&O
|September 16, 2005
PubMed
Summary

Vascular endothelial growth factor receptors (VEGFRs) are found on tumor cells, not just blood vessel cells. This discovery offers new therapeutic targets for anti-VEGF cancer treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Promoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists: ASCO Recommendations for Academic Medical Centers.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

Enhancing efficacy of the MEK inhibitor trametinib with paclitaxel in <i>KRAS</i>-mutated colorectal cancer.

Therapeutic advances in medical oncology·2024
Same author

Leucine-Rich Alpha-2-Glycoprotein 1 Promotes Metastatic Colorectal Cancer Growth Through Human Epidermal Growth Factor Receptor 3 Signaling.

Gastroenterology·2024
Same author

Enhancing efficacy of the MEK inhibitor trametinib with paclitaxel in <i>KRAS</i> -mutated colorectal cancer.

bioRxiv : the preprint server for biology·2024
Same author

Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer.

Molecular cancer therapeutics·2023
Same author

Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo.

PloS one·2023

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Vascular endothelial growth factor (VEGF) is crucial for tumor angiogenesis.
  • VEGF signaling involves ligands, tyrosine kinase receptors (VEGFRs), and neuropilin co-receptors.
  • VEGFRs are traditionally known to be on endothelial cells.

Purpose of the Study:

  • To review the effects and interactions of VEGFRs on endothelial cells.
  • To present evidence for VEGFR expression and function on tumor cells.
  • To explore the implications of VEGFRs on tumor cells for anti-VEGF therapy.

Main Methods:

  • Literature review of existing studies on VEGF and VEGFR.
  • Analysis of evidence for VEGFR expression in non-endothelial and tumor cells.

Related Experiment Videos

  • Discussion of the functional implications of VEGFRs in tumor cells.

    • Main Results:

    • Emerging evidence shows VEGFR expression on various non-endothelial cells, including tumor cells.
    • VEGFRs are functional in these non-endothelial systems.
    • VEGF signaling in tumor cells adds complexity to the tumor microenvironment.

    Conclusions:

    • VEGFR expression on tumor cells is a significant finding.
    • This novel expression expands the understanding of VEGF's role in cancer.
    • Targeting VEGFRs on tumor cells may refine anti-cancer treatment strategies.